Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients-Reference-Cited by-同舟云学术

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Published:2015-06-22 Issue:7 Volume:125 Page:2795-2807
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Rice Lisa M.,Padilla Cristina M.,McLaughlin Sarah R.,Mathes Allison,Ziemek Jessica,Goummih Salma,Nakerakanti Sashidhar,York Michael,Farina Giuseppina,Whitfield Michael L.,Spiera Robert F.,Christmann Romy B.,Gordon Jessica K.,Weinberg Janice,Simms Robert W.,Lafyatis Robert

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference51 articles.

1. Type beta transforming growth factor: a bifunctional regulator of cellular growth.

2. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

3. Transforming Growth Factor-?.

4. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.

5. Derynck R, Miyaono K, eds. The TGF-Beta Family. Cold Spring Harbor Monograph Series 50. Cold Spring Harbor, New York, USA: Cold Spring Harbor Laboratory Press; 2007.

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis;Inflammopharmacology;2024-08-21

2. Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-12

3. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

4. TGF-β signaling: critical nexus of fibrogenesis and cancer;Journal of Translational Medicine;2024-06-26

5. Advancements in targeted therapies for scleroderma: navigating the complexities of systemic and localized disease management;InterConf;2024-06-19